Primary |
Product Used For Unknown Indication |
66.7% |
Tinea Pedis |
33.3% |
|
Activities Of Daily Living Impaired |
33.3% |
Incorrect Drug Administration Duration |
33.3% |
Paraesthesia |
33.3% |
|
Secondary |
Product Used For Unknown Indication |
43.6% |
Cardiac Disorder |
10.6% |
Diabetes Mellitus |
10.6% |
Back Pain |
9.6% |
Pain |
6.9% |
Abnormal Sensation In Eye |
6.4% |
Hypertension |
2.8% |
Diuretic Therapy |
1.8% |
Intraocular Pressure Increased |
1.8% |
Intraocular Pressure Test Abnormal |
0.9% |
Onychomycosis |
0.9% |
Acne |
0.5% |
Arthralgia |
0.5% |
Blood Pressure |
0.5% |
Eye Disorder |
0.5% |
Fungal Infection |
0.5% |
Hypercholesterolaemia |
0.5% |
Insomnia |
0.5% |
Prophylaxis |
0.5% |
Rash |
0.5% |
|
Vomiting |
25.0% |
Fatigue |
8.3% |
Myalgia |
8.3% |
Sleep Disorder |
8.3% |
Abasia |
4.2% |
Asthenia |
4.2% |
Back Pain |
4.2% |
Chest Discomfort |
4.2% |
Confusional State |
4.2% |
Drug Hypersensitivity |
4.2% |
Drug Ineffective |
4.2% |
Dyspnoea |
4.2% |
Nausea |
4.2% |
Off Label Use |
4.2% |
Skin Irritation |
4.2% |
Tunnel Vision |
4.2% |
|
Concomitant |
Product Used For Unknown Indication |
12.5% |
Drug Use For Unknown Indication |
12.4% |
Hypertension |
9.9% |
Pain |
7.7% |
Rash |
7.5% |
Constipation |
5.8% |
Febrile Neutropenia |
5.3% |
Prostate Cancer |
4.7% |
Proteus Infection |
4.7% |
Pseudomonas Infection |
4.7% |
Supplementation Therapy |
3.8% |
Gastrooesophageal Reflux Disease |
3.3% |
Pyrexia |
2.8% |
Renal Cancer Metastatic |
2.5% |
Thrombosis Prophylaxis |
2.5% |
Cough |
2.2% |
Multiple Myeloma |
2.2% |
Back Pain |
1.9% |
Insomnia |
1.9% |
Ear Infection |
1.7% |
|
Vaginal Infection |
9.6% |
Vomiting |
8.4% |
Weight Decreased |
7.2% |
White Blood Cell Count Decreased |
7.2% |
Gastrointestinal Perforation |
6.0% |
Metabolic Disorder |
6.0% |
Skin Ulcer |
6.0% |
Tachycardia |
6.0% |
Death |
4.8% |
Decreased Appetite |
4.8% |
Peritonitis |
4.8% |
Tonsillectomy |
4.8% |
Rash |
3.6% |
Type 2 Diabetes Mellitus |
3.6% |
Urticaria |
3.6% |
Vertigo |
3.6% |
Asthenia |
2.4% |
Cardiovascular Disorder |
2.4% |
Crohn's Disease |
2.4% |
Foetal Exposure During Pregnancy |
2.4% |
|